Assessment of the prognostic factors in patients with pulmonary carcinoid tumor: a population-based study

Author:

Huang Yiwei1,Yang Xiaodong1,Lu Tao1,Li Ming2,Zhao Mengnan1,Yang Xingyu2,Ma Ke1,Wang Shuai1ORCID,Zhan Cheng1ORCID,Liu Yu1,Wang Qun1

Affiliation:

1. Department of Thoracic Surgery; Zhongshan Hospital; Fudan University; No. 180, Fenglin Road Shanghai 200032 China

2. Eight-year Program Clinical Medicine; Shanghai Medical College; Fudan University; Shanghai 200032 China

Funder

National Natural Science Foundation of China

Research Program of Shanghai Health and Family Planning Commission

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference28 articles.

1. Systemic therapy for pulmonary carcinoids;Marquez-Medina;Lung Cancer,2015

2. Neuroendocrine tumors of the lung: an update;Rekhtman;Arch. Pathol. Lab. Med.,2010

3. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid;Travis;Am. J. Surg. Pathol.,1998

4. Pulmonary atypical carcinoid: predictors of survival in 106 cases;Beasley;Hum. Pathol.,2000

5. Carcinoid lung tumors-incidence, treatment and outcomes: a population-based study;Naalsund;Eur. J. Cardiothorac. Surg.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3